Exhibit 10.1
Amended and Restated Non-Employee Director Compensation Policy
Effective Date: January 14, 2022
Each member of the Board of Directors (the “Board”) of NeuroBo Pharmaceuticals, Inc., a Delaware corporation (the “Company”) who is not also serving as an employee of the Company or any of its subsidiaries (each such member, an “Non-Employee Director”) will receive the compensation described in this Amended and Restated Non-Employee Director Compensation Policy (this “Policy”). A Non-Employee Director may decline all or any portion of his or her compensation by giving notice to the Company prior to the date cash is to be paid or equity awards are to be granted, as the case may be. This Policy will be effective as of January 14, 2022 (the “Effective Date”). This Policy may be amended at any time in the sole discretion of the Board, or by the Compensation Committee of the Board (the “Compensation Committee”) at the recommendation of the Board. Unless otherwise defined herein, capitalized terms used in this Policy will have the meaning given to such terms in the Company’s 2019 Equity Incentive Plan or if such plan is no longer in use, the meaning given to such terms or any similar terms in the primary successor to such plan (in either case, the “Plan”).
ANNUAL CASH COMPENSATION
Commencing on the Effective Date, each Non-Employee Director will receive the cash compensation set forth below for service on the Board. The annual cash compensation amounts will be payable in equal quarterly installments, in arrears no later than 30 days following the end of each quarter in which the service occurred (each, a “Quarterly Date”). Each annual retainer set forth below will be pro-rated based on days served in the applicable fiscal year of the Company, with the pro-rated amount paid for the first fiscal quarter of the Company in which the Non-Employee Director provides the service, and regular full quarterly payments to be paid thereafter. All annual cash fees are vested upon payment.
1.ANNUAL BOARD SERVICE RETAINER:
(a)All Non-Employee Directors: $40,000
(b)Chair of the Board (as applicable): $35,000 (in addition to above)
(c)Lead Independent Director (as applicable): $20,000 (in addition to above)
2.ANNUAL COMMITTEE MEMBER SERVICE RETAINER:
(a)Member of the Audit Committee: $9,000
(b)Member of the Compensation Committee: $6,000
(c)Member of the Nominating and Corporate Governance Committee: $4,000
| 3. | ANNUAL COMMITTEE CHAIR SERVICE RETAINER (IN LIEU OF COMMITTEE MEMBER SERVICE RETAINER): |
(a)Chair of the Audit Committee: $18,000
(b)Chair of the Compensation Committee: $12,000
(c)Chair of the Nominating and Corporate Governance Committee: $8,000
EQUITY COMPENSATION
Equity awards will be granted under the Plan. All stock options granted under this Policy will be Nonstatutory Stock Options (as defined in the Plan), with a term of ten years from the date of grant (subject to earlier termination upon a termination of the Non-Employee Director’s service to the Company) and an exercise price per share equal to 100% of the Fair Market Value (as defined in the Plan) of a share of the Company’s common stock on the date of grant.